日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Defining Structure-Function Relationships of Amphiphilic Excipients Enables Rational Design of Ultra-Stable Biopharmaceuticals

明确两亲性辅料的结构-功能关系有助于合理设计超稳定生物制药

Prossnitz, Alexander N; Nguyen, Leslee T; Eckman, Noah; Borkar, Suraj; Tetef, Samantha; Autzen, Anton A A; Fuller, Gerald G; Appel, Eric A

ER-Targeted PET for Initial Staging and Suspected Recurrence in ER-Positive Breast Cancer

ER靶向PET在ER阳性乳腺癌的初始分期和疑似复发中的应用

Ulaner, Gary A; Silverstein, Mel; Nangia, Chaitali; Tetef, Merry; Vandermolen, Louis; Coleman, Colleen; Khan, Sadia; MacDonald, Heather; Patel, Trushar; Techasith, Tust; Mauguen, Audrey

Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus

一项针对接受依维莫司治疗的激素受体阳性乳腺癌女性患者的非甾体类漱口水预防和治疗口腔炎的II期随机试验

Peddi, Parvin F; Tetef, Merry; Coluzzi, Paul; Arzoo, Karo K; Hu, Eddie H; Berkowitz, Maurice J; Chan, David; Moore, Dennis Jr; Adams, Brad; Wang, Xiaoyan; Hurvitz, Sara A

Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer

吉西他滨联合顺铂治疗既往接受过大量治疗和极少治疗的转移性乳腺癌的II期研究

Chew, Helen K; Doroshow, James H; Frankel, Paul; Margolin, Kim A; Somlo, George; Lenz, Heinz-Josef; Gordon, Michael; Zhang, Wu; Yang, Dongyun; Russell, Christy; Spicer, Darcy; Synold, Tim; Bayer, Robert; Hantel, Alexander; Stiff, Patrick J; Tetef, Merry L; Gandara, David R; Albain, Kathy S

Mitomycin C and menadione for the treatment of advanced gastrointestinal cancers: a phase II trial

丝裂霉素C和甲萘醌治疗晚期胃肠道癌症:一项II期试验

Tetef, M; Margolin, K; Ahn, C; Akman, S; Chow, W; Coluzzi, P; Leong, L; Morgan, R J Jr; Raschko, J; Shibata, S